TransCode Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.

About RNAZ

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Newton, MA.

CEO

Thomas A. Fitzgerald

CEOThomas A. Fitzgerald

Employees

Employees7

Headquarters

Newton, Massachusetts

HeadquartersNewton, Massachusetts

Founded

2016

Founded2016

Employees

Employees7

RNAZ Key Statistics

Market cap

9.28M

Market cap9.28M

Price-Earnings ratio

-0.01

Price-Earnings ratio-0.01

Dividend yield

—

Dividend yield—

Average volume

4.24M

Average volume4.24M

High today

$0.4681

High today$0.4681

Low today

$0.3113

Low today$0.3113

Open price

$0.3165

Open price$0.3165

Volume

10.25M

Volume10.25M

52 Week high

$66.33

52 Week high$66.33

52 Week low

$0.2196

52 Week low$0.2196

TransCode Therapeutics

Why Robinhood?

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Newton, MA. Show more

RNAZ Key Statistics

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Newton, MA.